ERVACCINE TECHNOLOGIES
Ervaccine Technologies a developer of next-generation cancer vaccines that targets endogenous retroviruses.
ERVACCINE TECHNOLOGIES
Industry:
Biotechnology Pharmaceutical
Founded:
2019-01-10
Address:
Lyon, Rhone-Alpes, France
Country:
France
Total Employee:
1+
Status:
Active
Total Funding:
2.5 M EUR
Similar Organizations
Alchemab Therapeutics
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Seed Round - Ervaccine Technologies